Eurepa MF 1 Tablet

Repaglinide (1mg) + Metformin (500mg) Primary uses of : Type 2 diabetes
*
₹ 131.80 incl tax
Composition Repaglinide (1mg) + Metformin (500mg)
Potentially Unsafe With Alcohol
Side Effect Common Side Effects of Eurepa MF are Nausea, Loss of appetite, Altered taste, Stomach pain, Diarrhoea, Hypoglycemia (low blood sugar level).
How to works How Eurepa MF Tablet works Eurepa MF 1 Tablet is a combination of two antidiabetic medicines: Repaglinide and metformin. Repaglinide is a meglitinide analogue which increases the amount of insulin released by the pancreas. This prevents blood glucose from rising very high after meals. Metformin is a biguanide which decreases the production and absorption of sugar in your body and allows better use of existing insulin. Together, they provide better control of blood sugar.